Navigation Links
Cytogel Pharma, LLC. Announces Presentation at the American Society of Anesthesiologists meeting in Chicago on October 18, 2011, Describing Results From its First Human Study, Part of the Phase I Program for Cyt-1010
Date:10/28/2011

DARIEN, Conn., Oct. 28, 2011 /PRNewswire/ -- Cytogel Pharma, LLC. is pleased to announce today the presentation at the American Society of Anesthesiologists of study results and completed analysis of a Phase I study of Cyt-1010.  Cyt-1010 is a proprietary compound and a chemically stabilized analogue of endomorphin 1, a naturally occurring pain modulator.  This trial was designed as a safety study in normal healthy volunteers with additional pharmacodynamic end points.  At the doses tested (up to 0.15 mg/kg) Cyt-1010 was generally well tolerated, and no severe adverse events or evidence of respiratory depression were reported.  The trial included additional tests to measure sensitivity to painful stimuli and statistically significant prolongation of the threshold time for cold pain sensation was recorded at a dose of 0.1 mg/kg.  Cyt-1010 is being developed for the treatment of acute and chronic pain conditions, including neuropathic pain and post-operative pain.

About Cytogel Pharma 

Cytogel Pharma, LLC. is a biopharmaceutical development company based in Darien, Connecticut, focused on developing promising early-stage programs that offer significant potential both as platform technologies and high value product candidates. The company's portfolio includes novel analgesic product candidates and broadly useful polymer and hydrogel drug delivery platform technologies. Cytogel will develop products from these platform technologies to the point of demonstrated value and then license these products to other larger companies for the full scientific and clinical development and subsequent commercialization.  To learn more about Cytogel, please visit our website at www.cytogelpharma.com.

CONTACT: C. Dean Maglaris, 203-966-9867


'/>"/>
SOURCE Cytogel Pharma, LLC.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Victory Pharma, Inc. Reports MGX006 Enters Into Pivotal Development Program
2. CB1400, Patented by Canopus BioPharma, Enters Phase II Clinical Trials for the Prevention of Mucositis in Patients With Cancer of the Head and Neck
3. FluoroPharma, Inc. to Report Preclinical Data on Alzheimers Disease and Prostate Cancer PET Imaging Agents
4. SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results
5. DOR BioPharma, Inc. Executes $400,000 Equity Investment Agreement With Numoda Corporation
6. Neurobiological Technologies Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical Program
7. Pangu BioPharma, aTyr Pharmas Subsidiary in Hong Kong, Files Three Patent Applications
8. Strativa Pharmaceuticals Development Partner, BioAlliance Pharma, Presents Phase III Study Results of Miconazole Lauriad(R) for the Treatment of Oropharyngeal Candidiasis
9. Northern Light Adds 4,000 Bio-Pharma, Health Sciences and General Business News and Journal Sources from EBSCO Publishing
10. SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
11. SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... , 2. Juli 2015 BGI gab ... in Hongkong vom American College of Pathologists ... ist das erste klinische Next-Generation-Sequencing Labor, das ... CAP-Zertifkat erhält und somit die höchsten Standards ... bestehenden US FDA - 21 CFR Part ...
(Date:7/2/2015)...  AbbVie (NYSE: ABBV ) will announce its ... before the market opens. AbbVie will host ... 8 a.m. Central time (9 a.m. Eastern). It will ... www.abbvieinvestor.com . An archived edition of the call will ... About AbbVie AbbVie is a global, research-based ...
(Date:7/2/2015)... DUBLIN , June 25, 2015 ... the addition of the "Veterinary / Animal Vaccines ... to 2020" report to their offering. ... $7,197.9 Million by 2020 from $5,507.3 Million in 2015, ... Major factors fueling market growth are growing ...
Breaking Medicine Technology:BGI erhält Akkreditierung vom College of American Pathologists (CAP) 2Veterinary / Animal Vaccines Market 2015 - Global Forecast to 2020 for the $7.19 Billion Industry 2
... LLC announced today that the United States Patent and Trademark ... illumination technology and that a second patent has been allowed. ... in the United States and around the world we,re very ... of AccuVein. "Our technology team has built a stellar portfolio ...
... Corporation (NYSE: CFN ), a global leading medical technology ... on Thursday, May 5 following the close of trading on the ... webcast and conference call on May 5 at 2 p.m. PDT ... fiscal 2011, ended on March 31, 2011. To access the call ...
Cached Medicine Technology:Award Winning Vascular Imaging Device Company Announces New Patents 2CareFusion Will Host an Earnings Conference Call on May 5 to Discuss the Results for the Third Quarter Fiscal 2011 2
(Date:7/3/2015)... ... , ... Every year, One-to-1 Fitness and the Red Deer Fit Body ... Deer community with free fitness training and indoor fitness boot camp classes for 24 ... raised thousands of charity dollars and ended with a $10,000 donation to the Jumpstart ...
(Date:7/2/2015)... ... ... Following the recent report by JAMA Internal Medicine published on ... Samir Becic emphatically declared a war on obesity in the United States. , "Obesity ... must understand the magnitude of this discovery. For that reason, I am declaring, along ...
(Date:7/2/2015)... , ... July 02, 2015 , ... In 2012, Patrick Achebe realized that the gift ... alone. He sat down to write his first poem, and three years later he was ... was special and worth sharing with the world. "I have always believed that the best ...
(Date:7/2/2015)... Md. (PRWEB) , ... July 02, 2015 , ... Six ... in his solo cross-country walk to raise awareness and money for the Pulmonary ... expects to arrive at PHA’s headquarters near Washington, D.C. by mid-September. He left Glasgow, ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... R. Krishnareddy, M.D., to the orthopedic and spine surgery team at their Anaheim ... strains, bursitis, and tendonitis. Along with the spine and spine surgery, Dr. Krishnareddy ...
Breaking Medicine News(10 mins):Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 4Health News:Patrick Achebe Releases Debut Book, Whispering Waves: Poems for Everyday Grace 2Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 2Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 3Health News:Healthpointe Welcomes Dr. Divakar R. Krishnareddy to its Orthopedic Team in Anaheim 2Health News:Healthpointe Welcomes Dr. Divakar R. Krishnareddy to its Orthopedic Team in Anaheim 3
... Trump Genetics in Facial AgingARLINGTON HEIGHTS, Ill., Feb. 3 ... may not be the best predictor of how you,ll ... opposite. The study, involving identical twins, suggests that despite ... a person,s perceived age. Results just published on the ...
... NCCN Guidelines for Breast Cancer and Breast Cancer ... on when to use MRIs in breast cancer ... for evaluative purposes, and new cosmetic recommendations for ... Feb. 3 The National Comprehensive Cancer Network ...
... Needs as the Leader in Vitamin D OfferingsNORTHRIDGE, Calif., ... recently adopted 12 new polices associated with public health ... leading concern. APHA,s new policies, approved during their ... the major public health concerns for both children and ...
... Feb. 3 February ... heart healthy is a year-round proposition. Eating a ... of heart health. However, a new study shows ... recommendation: taking dietary supplements.To view the Multimedia News ...
... Mass., Feb. 3 NxStage Medical, Inc. (Nasdaq: ... announced plans to release its financial results for the fourth ... March 12, 2009 before the opening of the financial markets.NxStage ... Time on Thursday, March 12, 2009 to discuss its fourth ...
... Baker & McKenzie, and Bankstreet Group,LLC., will co-sponsor the ... and pharma industries in New York City on February ... Internationally recognized radiation therapy systems expert, James G.,Schwade, M.D., ... the,CyberKnife Center of Miami and Palm Beach, Florida,( http://www.morsecyberknife.com ...
Cached Medicine News:Health News:Divorce, Antidepressants, or Weight Gain/Loss Can Add Years to Your Face 2Health News:NCCN Updates Breast Cancer and Breast Cancer Risk Reduction Guidelines 2Health News:NCCN Updates Breast Cancer and Breast Cancer Risk Reduction Guidelines 3Health News:NCCN Updates Breast Cancer and Breast Cancer Risk Reduction Guidelines 4Health News:APHA Lists Vitamin D Deficiency as Top Public Health Issue 2Health News:APHA Lists Vitamin D Deficiency as Top Public Health Issue 3Health News:Video: Cardiologists Recommend Lifestyle Habits for Healthy Hearts 2Health News:Video: Cardiologists Recommend Lifestyle Habits for Healthy Hearts 3Health News:NxStage to Report Fourth Quarter and Full Year 2008 Financial Results 2Health News:James G. Schwade, M.D. to Deliver Keynote Address to Financial and Investment Industry in New York 2
... the osteotomy staples is quite similar to the type ... inner position of the anti recoil contours and the ... There are 3 kinds of staples: 1. Straight ... staples can have 3 different widths: 20mm, 26 mm ...
The staple fixation system provides a simple means of attaching tissue to bone....
... Cement consists of a two ... bone cement liquid within a ... polyethylene bag,containing bone cement powder ... interiors of the blister pack,and ...
A "doughy" type of bone cement intended for manual application....
Medicine Products: